BEONE MEDICINES LTD. (ONC) FY2025 Annual P&L / Income Statement

BEONE MEDICINES LTD. (ONC) FY2025 Annual P&L / Income Statement

Income statement for 2025-01-01 through 2025-12-31. View: Product and Service by Geographical. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Total revenues

5,343,033,000 US dollars

Cost of revenue (calculated)

668,540,000 US dollars

Gross profit

4,674,493,000 US dollars

Operating expenses (calculated)

4,227,357,000 US dollars

Income (loss) from operations

447,136,000 US dollars

Other income (expense), net (calculated)

negative 30,282,000 US dollars

Income (loss) before income taxes

416,854,000 US dollars

Income tax expense

129,921,000 US dollars

Net income (loss)

286,933,000 US dollars

Other - Other

0 US dollars

Other - CHINA

20,168,000 US dollars

Other - UNITED STATES

39,078,000 US dollars

Other - Europe- total revenue

1,726,000 US dollars

Product revenue, net - Other

171,809,000 US dollars

Product revenue, net - CHINA

1,659,363,000 US dollars

Product revenue, net - UNITED STATES

2,841,246,000 US dollars

Product revenue, net - Europe- total revenue

609,643,000 US dollars

Cost of sales - product

668,540,000 US dollars

Selling, general and administrative

2,081,489,000 US dollars

Research and development

2,145,868,000 US dollars

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.